| answer text |
<p> </p><p>The UK Government is the second largest Government supporter of research
and development for new health products for infectious diseases. In August 2013, following
an open competition, funding of £138 million (for the period 2013 -2018) was announced
to support the development of a range of new health technologies, including: drugs,
diagnostics, microbicides, vector control and vaccines for infectious diseases that
predominantly affect developing countries, such as TB, HIV, malaria, sleeping sickness
and diarrhoeal diseases. Additionally, DFID funds major trials of new methods of delivery
of prevention alongside the Medical Research Council and Wellcome Trust, the World
Health Organisation and others.</p><p> </p><p>DFID works closely with others involved
in product development research, including funders, to identify opportunities to address
shortfalls in research funding.</p>
|
 |
